Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

Also called NCT01572129

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01572129
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01572129. Randomized; double masking; primary purpose prevention. Start 2011-11 (registry gives no type); primary completion 2012-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy
Condition
Acute Coronary Syndrome
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Placebo
Lead sponsor
Campus Bio-Medico University (class: other)

Record details

Record id
cardio:ct-nct01572129
Content hash
e7af1f949acb1af98b97fb92a67fb9ca67bcc29bb80156e7c6bb6bbc5eb73906